Di Yin
- Nephrology top 2%
- Cancer Research top 10%
- Molecular Biology top 10%
- CRISPR and Genetic Engineering 5
- Biotechnology top 10%
-
- SARS-CoV-2 and COVID-19 Research 7
-
- Electrocatalysts for Energy Conversion 7
-
- Electromagnetic wave absorption materials 6
-
- Advanced Antenna and Metasurface Technologies 5
-
- Virus-based gene therapy research 5
-
- Vaccine Coverage and Hesitancy 5
-
- Herpesvirus Infections and Treatments 4
- Co-authors
- Bi‐Cheng LiuLin‐Li LvZuo‐Lin LiJing-Yuan CaoBin WangTao‐Tao TangMin WuRi‐Ning Tang
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Di Yin
65 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Nephrology 222
- Cancer Research 218
- Molecular Biology 863
- Biotechnology 73
- Business and International Management 15
Countries citing papers authored by Di Yin
This map shows the geographic impact of Di Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di Yin more than expected).
Fields of papers citing papers by Di Yin
This network shows the impact of papers produced by Di Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di Yin. The network helps show where Di Yin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Di Yin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 8 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | CRISPR-GPT for agentic automation of gene-editing experimentsbreakdown → | 2025 | 16 |
| 6 | 2025 | 0 | |
| 7 | 2025 | 14 | |
| 8 | 2025 | 0 | |
| 9 | 2025 | 2 | |
| 10 | 2024 | 11 | |
| 11 | 2024 | 16 | |
| 12 | 2024 | 1 | |
| 13 | 2023 | 15 | |
| 14 | 2023 | 2 | |
| 15 | 2022 | 6 | |
| 16 | Targeting herpes simplex virus with CRISPR–Cas9 cures herpetic stromal keratitis in micebreakdown → | 2021 | 122 |
| 17 | 2021 | 135 | |
| 18 | 2021 | 13 | |
| 19 | Exosomal miR-125b-5p deriving from mesenchymal stem cells promotes tubular repair by suppression of p53 in ischemic acute kidney injurybreakdown → | 2021 | 217 |
| 20 | 2002 | 46 |
About Di Yin
Di Yin is a scholar working on Nephrology, Health and Aging, having authored 73 papers that have together received 1.7k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (7 papers), Electrocatalysts for Energy Conversion (7 papers), Electromagnetic wave absorption materials (6 papers), CRISPR and Genetic Engineering (5 papers), Advanced Antenna and Metasurface Technologies (5 papers), Virus-based gene therapy research (5 papers), Vaccine Coverage and Hesitancy (5 papers) and Herpesvirus Infections and Treatments (4 papers). The work is most often cited by research in Nephrology (222 citations), Cancer Research (218 citations) and Molecular Biology (863 citations). Di Yin has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Bi‐Cheng Liu, Lin‐Li Lv, Zuo‐Lin Li, Jing-Yuan Cao, Bin Wang, Tao‐Tao Tang, Min Wu, Ri‐Ning Tang, Jiaxu Hong and Yujia Cai. Their work appears in journals such as Nature Communications, Nano Letters and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.